Ending the pandemic is clearly the top public-health priority for the incoming Biden administration. Will action on drug pricing, ACA reform and data privacy follow?
Pandemic or no, pharma needs to push drug pricing dialogue
Although the world is still months away from a COVID-19 vaccine, it’s imperative that pharma companies have the conversation right now about the cost of innoculation.
Vaccine makers and lawmakers stress importance of accessible COVID-19 vaccine